Abstract Prevalence of pulmonary arterial hypertension (PAH) was studied by Echocardiography and Doppler in 43 splenectomised patients with various disorders 1-20 years after splenectomy. PAH was detected only in thalassemia -brosis groups comprising a total of 21 patients. Six patients out of 21 was found to have PAH with mean pulmonary arterial pressure of 46.28 ± 28.17 mmHg. Twenty one controls having similar duration and type of disease also were assessed for PAH in this case control study 3/21 had PAH in this control group. The difference in number of patients showing pulmonary hypertension between case and control though the difference in pulmonary arterial pressure bep<0.0029) with control group showing a mean pulmonary arterial pressure of 25 ± 19 mmHg.
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Platelet count in the splenectomised group was signifwith and without splenectomy. Patients undergoing splenectomy due to trauma, immune thrombocytopenia, sideroblastic anemia, extra hepatic portal hypertension, autoimmune hemolytic anemia did not show PAH after splenectomy even years after the procedure PAH following splenectomy is common after certain disorders and control patients with these diseases have tendency to develop PAH even without splenectomy. Pulmonary thromboembolism may be an important pathophysiological mechanism leading to this -brosis should have regular evaluation of pulmonary arterial pressure whether he/she has been splenectomised or not.
Introduction
Splenectomy is widely performed for treating various hematological and non-hematological conditions [1] [2] [3] [4] [5] [6] . There are debates as to whether there is increased risk of pulmonary arterial hypertension (PAH) following splenectomy either as a result of increased thromboembolism [7] or due -tion function [8] .
There are also debates whether the diseases for which splenectomy is done itself predisposes to PAH. PAH again can be caused by several pathophysiologic mechanisms (i) overload) (ii) Occlusion of blood vessels (thromboembolic) or (iii) Plexiform arteriopathy as is classically associated with primary pulmonary hypertension.
Conditions for which splenectomy is done may often be associated with anemia and splenectomy itself produce a hypercoagulable state predisposing to pulmonary throm-ORIGINAL ARTICLE boembolism. In this case control study we matched these clinical conditions which has produced pulmonary hypertension following splenectomy with disease matched controls. In addition there were several other category of patients who underwent splenectomy but did not develop PAH for these patients no control was used.
Materials and methods

Patients
Forty three patients of either sex (25 female and 18 males) underwent splenectomy for various indications 1-20 years back were included in this study. Of these 43 patients, 21 patients were found to have diseases where some of the patieints had PAH.
Controls
Twenty one control non-splenectomized subjects were matched with similar spectrum and duration of disease as in the study subjects with diseases associated with PAH.
Institutional ethics committee permitted this study and detailed informed consent was taken from each of the patients after describing them the objective of the study and the procedure to be followed. They all consented for the study.
All the patients and controls were examined clinically, had routine hemogram, blood chemistry, transfusion history, transfusion transmitted viral infection checked. Chest X-ray, ECG was routinely evaluated in all the patients. Auchecked in all the patients as also the screening coagulation tests comprising of aPTT, PT and TT.
Pulmonary arterial pressure was measured using standard published criteria using echocardiography and Dopjet acrossthe tricuspid valve [4, 6] . Those patients who were pressure of >25 mmHg at rest underwent ventilation perfusion scan, spiral CT angiography of chest, arterial blood gas analysis and pulmonary function test in addition to regular investigations described above.
Results
patient group. Eleven female and 10 male were in the control group (22-38 years) patients were splenectomised 1-20 years back (Mean ± 1SD 6.6 years ± 4.2 years). The mean ± 1SD duration for splenectomy to detection of pulmonary hypertension was 11.14 ± 6.49 years which was not very different from the 21 controls with whose disease was detected 3.5-11.5 years earlier.
Pulmonary hypertension was detected in the following group of patients -brosis, hereditary sphereocytosis. Non-splenectomised control of hereditary sphereoctyosis did not show any evidence of PAH.
In addition to above diagnostic group a large number of patient with immune thrombocytopenic purpura (ITP) [7] who underwent splenectomy did not develop PAH. Similarly few patients of unstable hemoglobin, AIHA, sideroblstic anemia, trauma, extra hepatic postal hypertension and atypical CML did not develop PAH 1-6 years after splenectomy. Mean pulmonary artery pressure (Mean ±1 SD) in patients mmHg Student's t-test p<0.0029) Six out of 21 splenectomised patients and 3 out of 21 cases and duration matched controls developed PAH ( 2 test p>0.05).
and non-splenectomised group had severe PAH (Mean PAP >45 mmHg) had abnormal chest X-ray and clear cut right ventricular hypertrophy on 12 lead ECG. These patients were clinically symptomatic where as other patients with PAH were clinically asymptomatic. Pulmonary thromboembolism was detected in 3/6 (50%) cases 2/3 (60%) controls. The patients showing thromboembolism were patients of higher in the cases compared to controls (t-test p < 0.0029). The details of the patient and control have been presented in Tables 1-2 and similar distribution of cases and matched controls are shown in Fig. 1a and b.
Discussion
Pulmonary hypertension a hitherto unrecognized complication of splenectomy has its own pathologic import and hematologists have to include this complication also while taking decision to go ahead with the procedure. The underlying pathogenic mechanism is unclear but function of spleen, abnormal erythrocytes may remain in circulation for longer period of time and may trigger platelet activation which could then be trapped in pulmonary vascular bed [8, 9] . Such mechanism could be active in any patient who is splenectomised but would be aggravated in presence of hemolytic disorders [10] [11] [12] . There are other possible mechanisms under consideration i.e. splenectomy in portal hypertension may be associated in the hepatoportal shunt and hypoxia which may induce pulmonary hypertension.
In severe anemia higher volume of blood passing through pulmonary circuit may cause pulmonary hypertension. Many conditions associated with antiphospholipid
